Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

Europe - BIT:CRL - IT0005331019 - Common Stock

22.8 EUR
+0.15 (+0.66%)
Last: 10/21/2025, 10:57:29 AM
Fundamental Rating

5

CRL gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 20 industry peers in the Building Products industry. While CRL has a great health rating, its profitability is only average at the moment. While showing a medium growth rate, CRL is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CRL had positive earnings in the past year.
In the past year CRL had a positive cash flow from operations.
Each year in the past 5 years CRL has been profitable.
CRL had a positive operating cash flow in each of the past 5 years.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.29%, CRL is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.29%, CRL is in the better half of the industry, outperforming 70.00% of the companies in the same industry.
With a decent Return On Invested Capital value of 8.69%, CRL is doing good in the industry, outperforming 70.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CRL is in line with the industry average of 11.08%.
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROIC 8.69%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CRL has a Profit Margin of 10.34%. This is in the better half of the industry: CRL outperforms 80.00% of its industry peers.
CRL's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 11.63%, CRL belongs to the best of the industry, outperforming 85.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CRL has declined.
Looking at the Gross Margin, with a value of 45.73%, CRL is in line with its industry, outperforming 55.00% of the companies in the same industry.
CRL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

CRL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CRL remains at a similar level compared to 1 year ago.
The number of shares outstanding for CRL has been increased compared to 5 years ago.
Compared to 1 year ago, CRL has an improved debt to assets ratio.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 5.58 indicates that CRL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.58, CRL belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
CRL has a debt to FCF ratio of 1.66. This is a very positive value and a sign of high solvency as it would only need 1.66 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.66, CRL belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that CRL is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, CRL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Altman-Z 5.58
ROIC/WACC1.11
WACC7.8%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.58 indicates that CRL should not have too much problems paying its short term obligations.
CRL has a Current ratio of 1.58. This is comparable to the rest of the industry: CRL outperforms 60.00% of its industry peers.
A Quick Ratio of 1.13 indicates that CRL should not have too much problems paying its short term obligations.
CRL's Quick ratio of 1.13 is fine compared to the rest of the industry. CRL outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.13
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CRL have decreased strongly by -19.15% in the last year.
The Earnings Per Share has been growing by 9.70% on average over the past years. This is quite good.
CRL shows a decrease in Revenue. In the last year, the revenue decreased by -2.99%.
Measured over the past years, CRL shows a quite strong growth in Revenue. The Revenue has been growing by 12.06% on average per year.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%

3.2 Future

The Earnings Per Share is expected to grow by 10.02% on average over the next years. This is quite good.
CRL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y-4.23%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
EPS Next 5YN/A
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 40.71 indicates a quite expensive valuation of CRL.
Based on the Price/Earnings ratio, CRL is valued a bit more expensive than 65.00% of the companies in the same industry.
CRL's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.69.
The Price/Forward Earnings ratio is 35.36, which means the current valuation is very expensive for CRL.
70.00% of the companies in the same industry are cheaper than CRL, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, CRL is valued quite expensively.
Industry RankSector Rank
PE 40.71
Fwd PE 35.36
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CRL's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CRL is more expensive than 85.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 29.57
EV/EBITDA 23.55
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of CRL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.2
EPS Next 2Y7.3%
EPS Next 3Y10.02%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.79%, CRL is not a good candidate for dividend investing.
CRL's Dividend Yield is slightly below the industry average, which is at 4.08.
With a Dividend Yield of 0.79, CRL pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.79%

5.2 History

On average, the dividend of CRL grows each year by 14.04%, which is quite nice.
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

30.38% of the earnings are spent on dividend by CRL. This is a low number and sustainable payout ratio.
The dividend of CRL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP30.38%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (10/21/2025, 10:57:29 AM)

22.8

+0.15 (+0.66%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-13 2025-11-13
Inst Owners26.81%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.56B
Analysts72
Price Target23.39 (2.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.79%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP30.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.67%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-3.4%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-1.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.52%
EPS NQ rev (1m)-13.33%
EPS NQ rev (3m)-13.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.3%
Revenue NQ rev (1m)-5.21%
Revenue NQ rev (3m)-5.21%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 40.71
Fwd PE 35.36
P/S 4.32
P/FCF 29.57
P/OCF 22.47
P/B 5.98
P/tB 43.52
EV/EBITDA 23.55
EPS(TTM)0.56
EY2.46%
EPS(NY)0.64
Fwd EY2.83%
FCF(TTM)0.77
FCFY3.38%
OCF(TTM)1.01
OCFY4.45%
SpS5.27
BVpS3.81
TBVpS0.52
PEG (NY)N/A
PEG (5Y)4.2
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROCE 10.92%
ROIC 8.69%
ROICexc 10.39%
ROICexgc 34.66%
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
FCFM 14.62%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexcg growth 3Y-17.51%
ROICexcg growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Debt/EBITDA 0.83
Cap/Depr 66.97%
Cap/Sales 4.62%
Interest Coverage 15.41
Cash Conversion 103.86%
Profit Quality 141.48%
Current Ratio 1.58
Quick Ratio 1.13
Altman-Z 5.58
F-Score6
WACC7.8%
ROIC/WACC1.11
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
EPS Next Y-4.23%
EPS Next 2Y7.3%
EPS Next 3Y10.02%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%
Revenue Next Year7.79%
Revenue Next 2Y8.61%
Revenue Next 3Y8.47%
Revenue Next 5YN/A
EBIT growth 1Y-15.06%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year86.33%
EBIT Next 3Y32.51%
EBIT Next 5YN/A
FCF growth 1Y46.46%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y34.27%
OCF growth 3Y16.42%
OCF growth 5Y11.49%